Fabrazyme (Agalsidase Beta) Drug Center: Guide to Drug Information for Professionals, Patients and Caregivers at RxList

Pill Identifier Search

May 27, 2012

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Fabrazyme

Parent's Guide to Crying and Colic Slideshow Pictures

Childhood Illnesses Every Parent Should Know Slideshow

Take the ADHD Quiz

font size

Fabrazyme Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Fabrazyme Prescribing Information: Indications & Dosage

Fabrazyme (agalsidase beta) is indicated for use in patients with Fabry disease. Fabrazyme (agalsidase beta) reduces globo-triaosylceramide (GL-3) deposition in capillary endothelium of the kidney and certain other cell types (see Clinical Studies).

Read the complete drug monograph for Fabrazyme »

What is Fabrazyme Prescribing Information?

Drug Description - Indications & Dosage - Side Effects & Drug Interactions - Warnings & Precautions - Contraindications - Medication Guide and More

What is Patient information?

Easy-to-read and understand detailed drug information and pill images for the patient or caregiver from Cerner Multum.

Fabrazyme Patient Information: Side Effects

Symptoms of allergic or infusion reactions including difficulty breathing; closing of the throat; hives; rash; itching; fever; shaking; chest tightness; high or low blood pressure; fast heartbeats; muscle pain; stomach pain; nausea or vomiting; dizziness; numbness or tingling; and headache have occurred upon injection of agalsidase beta in many patients. Most patients treated with agalsidase beta develop antibodies to agalsidase beta and many will develop symptoms of an infusion reaction. A slow rate of injection of the medication and pretreatment with other medications may decrease the sev...

Read the complete patient information for Fabrazyme »